BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34394090)

  • 21. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
    Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
    Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset.
    Zawada AM; Rogacev KS; Rotter B; Winter P; Marell RR; Fliser D; Heine GH
    Blood; 2011 Sep; 118(12):e50-61. PubMed ID: 21803849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.
    Doehn JM; Tabeling C; Biesen R; Saccomanno J; Madlung E; Pappe E; Gabriel F; Kurth F; Meisel C; Corman VM; Hanitsch LG; Treskatsch S; Heim K; Stegemann MS; Ruwwe-Glösenkamp C; Müller-Redetzky HC; Uhrig A; Somasundaram R; Spies C; von Bernuth H; Hofmann J; Drosten C; Suttorp N; Witzenrath M; Sander LE; Hübner RH
    Infection; 2021 Aug; 49(4):757-762. PubMed ID: 33825125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics.
    Ancuta P; Weiss L; Haeffner-Cavaillon N
    Eur J Immunol; 2000 Jul; 30(7):1872-83. PubMed ID: 10940876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission.
    Ortillon M; Coudereau R; Cour M; Rimmelé T; Godignon M; Gossez M; Yonis H; Argaud L; Lukaszewicz AC; Venet F; Monneret G
    Cytometry A; 2021 May; 99(5):466-471. PubMed ID: 33547747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of CD8⁺ T Cell Responses after Melanoma Antigen Targeting to CD169⁺ Antigen Presenting Cells in Mice and Humans.
    van Dinther D; Lopez Venegas M; Veninga H; Olesek K; Hoogterp L; Revet M; Ambrosini M; Kalay H; Stöckl J; van Kooyk Y; den Haan JMM
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30764534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposome induction of CD8
    Grabowska J; Affandi AJ; van Dinther D; Nijen Twilhaar MK; Olesek K; Hoogterp L; Ambrosini M; Heijnen DAM; Klaase L; Hidalgo A; Asano K; Crocker PR; Storm G; van Kooyk Y; den Haan JMM
    J Control Release; 2021 Mar; 331():309-320. PubMed ID: 33493613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
    Santodonato L; D'Agostino G; Nisini R; Mariotti S; Monque DM; Spada M; Lattanzi L; Perrone MP; Andreotti M; Belardelli F; Ferrantini M
    J Immunol; 2003 May; 170(10):5195-202. PubMed ID: 12734367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.
    Liu B; Dhanda A; Hirani S; Williams EL; Sen HN; Martinez Estrada F; Ling D; Thompson I; Casady M; Li Z; Si H; Tucker W; Wei L; Jawad S; Sura A; Dailey J; Hannes S; Chen P; Chien JL; Gordon S; Lee RW; Nussenblatt RB
    J Immunol; 2015 Jun; 194(11):5150-60. PubMed ID: 25911752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regular dose of gemcitabine induces an increase in CD14+ monocytes and CD11c+ dendritic cells in patients with advanced pancreatic cancer.
    Soeda A; Morita-Hoshi Y; Makiyama H; Morizane C; Ueno H; Ikeda M; Okusaka T; Yamagata S; Takahashi N; Hyodo I; Takaue Y; Heike Y
    Jpn J Clin Oncol; 2009 Dec; 39(12):797-806. PubMed ID: 19797418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity.
    Rempel H; Calosing C; Sun B; Pulliam L
    PLoS One; 2008 Apr; 3(4):e1967. PubMed ID: 18414664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
    Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
    J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated CD8+ T lymphocytes induce differentiation of monocytes to dendritic cells and restore the stimulatory capacity of interleukin 10-treated antigen-presenting cells.
    Wirths S; Reichert J; Grünebach F; Brossart P
    Cancer Res; 2002 Sep; 62(17):5065-8. PubMed ID: 12208762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood monocytes sample MelanA/MART1 antigen for long-lasting cross-presentation to CD8
    Faure F; Jouve M; Lebhar-Peguillet I; Sadaka C; Sepulveda F; Lantz O; Berre S; Gaudin R; Sánchez-Ramón S; Amigorena S
    Int J Cancer; 2018 Jan; 142(1):133-144. PubMed ID: 28884480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
    Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
    Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ Delivery of Antigen to DC-SIGN(+)CD14(+) Dermal Dendritic Cells Results in Enhanced CD8(+) T-Cell Responses.
    Fehres CM; van Beelen AJ; Bruijns SCM; Ambrosini M; Kalay H; Bloois LV; Unger WWJ; Garcia-Vallejo JJ; Storm G; de Gruijl TD; Kooyk YV
    J Invest Dermatol; 2015 Sep; 135(9):2228-2236. PubMed ID: 25885805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells.
    Pogue SL; Preston BT; Stalder J; Bebbington CR; Cardarelli PM
    J Interferon Cytokine Res; 2004 Feb; 24(2):131-9. PubMed ID: 14980077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.